Phase III multicenter randomized trial of the Dartmouth regimen ...

There was no difference in survival time and only a small, statistically nonsignificant increase in tumor response for stage IV melanoma patients treated ...

Phase III Multicenter Randomized Trial of the Dartmouth Regimen ...

CONCLUSION: There was no difference in survival time and only a small, statistically nonsignificant increase in tumor response for stage IV melanoma patients ...

Scolaris Language Selector Scolaris Language Selector ... Cochrane Review language. Select your preferred language for Cochrane Reviews and other content.

Phase III multicenter randomized trial of the Dartmouth ... - Synapse

Patients and Methods: In this multicenter phase III trial, 240 patients with measurable stage IV melanoma were randomized to receive the Dartmouth regimen ( ...

A randomized phase III study comparing dacarbazine, BCNU ...

... Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol. 1999 Sep;17(9):2745 ...

A randomized phase III study comparing dacarbazine ... - Nature

(1999) Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol 17: 2745–2752.

Multicenter phase III randomized trial of polychemotherapy (CVD ...

Meyers, et al. Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol, 17 ...

Phase III Multicenter Randomized Trial of the Dartmouth Regimen ...

PATIENTS AND METHODS: In this multicenter phase III trial, 240 patients with measurable stage IV melanoma were randomized to receive the Dartmouth regimen ( ...

Palliative therapy of disseminated malignant melanoma - The Lancet

Chapman, PB ∙ Einhorn, LH ∙ Meyers, ML ∙ et al. Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with ...

Treatment of metastatic malignant melanoma

: Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol 1999, 17:2745–2751 ...

Medline ® Abstracts for References 17,18 of 'Cytotoxic ...

Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. AU: Chapman PB, Einhorn LH, Meyers ...

Recent Advances in the Treatment of Metastatic Melanoma

Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol. 1999;17:2745-2751 ...

A randomized, controlled phase III trial of nab-Paclitaxel versus ...

In this open-label, multicenter phase III study, eligible patients were randomized 1 : 1 via a centralized system to nab-paclitaxel 150 mg/m2 administered i.v. ...

SYSTEMIC TREATMENT OF METASTATIC MELANOMA WITH ...

In another study, the Dartmouth regimen was used as the control arm in a phase III randomized trial evaluating the activity of Melacine, an allogeneic melanoma ...

Metastatic melanoma | Current Treatment Options in Oncology

Results of the large phase II study of the Dartmouth regimen. ... : A phase III multicenter randomized trial of ... : Randomized phase III trial of treatment with ...

Phase III trial of carboplatin and paclitaxel with or without sorafenib ...

Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. · Medicine. Journal of clinical oncology ...

Characteristics of long-survivor metastatic melanoma after ...

Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol. 1999 ...

Therapeutic Strategies for the Treatment of Metastatic Melanoma

Ernstoff M S, Houghton A N and Kirkwood J M,“Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic ...

Treatment algorithm of metastatic mucosal melanoma - Wang

... phase III multicenter randomized trial (7). Other than the Dartmouth regimen, agents as cisplatin/vinblastine and various cytokines were combined with ...

Chemotherapy for metastatic melanoma - Gogas - 2007 - Cancer

Phase III multicenter randomized trial of Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol. 1999; 17 ...